Nitika Pant Pai

Prof. Nitika Pant Pai


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2012 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
NPNitika Pant Pai
Nitika Pant Pai
CVCaroline Vadnais
Caroline Vadnais
CDClaudia Denkinger
Claudia Denkinger
NENora Engel
Nora Engel
MPMadhukar Pai
Madhukar Pai
Madhukar Pai and colleagues discuss a framework for envisioning how point-of-care testing can be applied to infectious diseases in low- and middle-income countries.

1 June 2003 in Environmental Health Perspectives
Verified
Journal Article
Open access
TWTimothy J Wade
Timothy J Wade
NPNitika Pant Pai
Nitika Pant Pai
JEJoseph N S Eisenberg
Joseph N S Eisenberg
JCJr John M Colford
Jr John M Colford
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.

2 April 2013 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
NPNitika Pant Pai
Nitika Pant Pai
JSJigyasa Sharma
Jigyasa Sharma
SSSushmita Shivkumar
Sushmita Shivkumar
SPSabrina Pillay
Sabrina Pillay
CVCaroline Vadnais
Caroline Vadnais
RPRosanna W Peeling
Rosanna W Peeling
By systematically reviewing the literature, Nitika Pant Pai and colleagues assess the evidence base for HIV self tests both with and without supervision.

1 October 2003 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
MPMadhukar Pai
Madhukar Pai
LFLaura L Flores
Laura L Flores
NPNitika Pant Pai
Nitika Pant Pai
AHAlan Hubbard
Alan Hubbard
LRLee W Riley
Lee W Riley
JCJohn M Colford
John M Colford

3 November 2017 in BMJ Open
Verified
Journal Article
Open access
PDF file
JDJana Daher
Jana Daher
RVRohit Vijh
Rohit Vijh
BLBlake Linthwaite
Blake Linthwaite
SDSailly Dave
Sailly Dave
JKJohn Kim
John Kim
NPNitika Pant Pai
Nitika Pant Pai
Objective Digital innovations with internet/mobile phones offer a potential cost-saving solution for overburdened health systems with high service delivery costs to improve efficiency of HIV/STI (sexually transmitted infections) control initiatives. However, their overall evidence has not yet been appraised. We evaluated the feasibility and impact of all digital innovations for all HIV/STIs. Design Systematic review. Setting/participants All settings/all participants. Intervention We classified digital innovations into (1) mobile health-based (mHealth: SMS (short message service)/phone calls), (2) internet-based mobile and/or electronic health (mHealth/eHealth: social media, avatar-guided computer programs, websites, mobile applications, streamed soap opera videos) and (3) combined innovations (included both SMS/phone calls and internet-based mHealth/eHealth). Primary and secondary outcome measures Feasibility, acceptability, impact. Methods We searched databases MEDLINE via PubMed, Embase, Cochrane CENTRAL and Web of Science, abstracted data, explored heterogeneity, performed a random effects subgroup analysis. Results We reviewed 99 studies, 63 (64%) were from America/Europe, 36 (36%) from Africa/Asia; 79% (79/99) were clinical trials; 84% (83/99) evaluated impact. Of innovations, mHealth based: 70% (69/99); internet based: 21% (21/99); combined: 9% (9/99). All digital innovations were highly accepted (26/31; 84%), and feasible (20/31; 65%). Regarding impacted measures, mHealth-based innovations (SMS) significantly improved antiretroviral therapy (ART) adherence (pooled OR=2.15(95%CI: 1.18 to 3.91)) and clinic attendance rates (pooled OR=1.76(95%CI: 1.28, 2.42)); internet-based innovations improved clinic attendance (6/6), ART adherence (4/4), self-care (1/1), while reducing risk (5/5); combined innovations increased clinic attendance, ART adherence, partner notifications and self-care. Confounding (68%) and selection bias (66%) were observed in observational studies and attrition bias in 31% of clinical trials. Conclusion Digital innovations were acceptable, feasible and generated impact. A trend towards the use of internet-based and combined (internet and mobile) innovations was noted. Large scale-up studies of high quality, with new integrated impact metrics, and cost-effectiveness are needed. Findings will appeal to all stakeholders in the HIV/STI global initiatives space.

1 May 2012 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
NPNitika Pant Pai
Nitika Pant Pai
BBBhairavi Balram
Bhairavi Balram
SSSushmita Shivkumar
Sushmita Shivkumar
JMJorge Luis Martinez-Cajas
Jorge Luis Martinez-Cajas
CCChristiane Claessens
Christiane Claessens
LJLawrence Joseph
Lawrence Joseph